Skip to content
Application 211852
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 90MG | No | No |
| 002 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 360MG | No | No |
| 003 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 180MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |